Neutrophil Lymphocyte Ratio (NLR) as a Predictor of Disease Severity and Mortality in Geriatric Patients with COVID-19
Creators
- 1. Associate Professor, Department of Geriatrics, Government Medical College, Aurangabad
- 2. Junior Resident 3rd Year, Department of Geriatrics, Government Medical College, Aurangabad
- 3. Professor, Department of Geriatrics, Government Medical College, Aurangabad
- 4. Senior Resident, Department of Geriatrics, Government Medical College, Aurangabad
- 5. Associate Professor, Department of Community Medicine, Government Medical College, Aurangabad
Description
Introduction: COVID-19 pandemic affected 44,696,984 people in India Geriatric (age 60 years and above) population is increasing globally. Older adults have been affected badly with COVID-19 Neutrophil lymphocyte ratio (NLR) is used in several diseases as an inflammatory marker in predicting prognosis. According to a recent study patients with severe COVID-19 are reported to have higher Neutrophil lymphocyte ratio ( NLR). In this study we aimed to assess the accuracy of Neutrophil lymphocyte ratio (NLR) as a predictor of disease severity and mortality in geriatric patients with COVID-19. Materials and Methods: 200 geriatric inpatients infected with COVID-19 were included in the study. Neutrophil lymphocyte ratio (NLR) at admission was recorded. Neutrophil lymphocyte ratio (NLR) cutoff was taken 3.5. Patients were categorized into mild, moderate, severe and critical cases according to criteria given by Maharashtra Task Force. Relationship between Neutrophil lymphocyte ratio (NLR) and disease outcome was assessed. A p value < 0.05 was taken as statistically significant. Results: The mean age of study sample was 69.00 ±7.09 years. A significant association was found between Neutrophil lymphocyte ratio (NLR) and disease severity (p -0.048) as well as mortality (p-0.041).
Abstract (English)
Introduction: COVID-19 pandemic affected 44,696,984 people in India Geriatric (age 60 years and above) population is increasing globally. Older adults have been affected badly with COVID-19 Neutrophil lymphocyte ratio (NLR) is used in several diseases as an inflammatory marker in predicting prognosis. According to a recent study patients with severe COVID-19 are reported to have higher Neutrophil lymphocyte ratio ( NLR). In this study we aimed to assess the accuracy of Neutrophil lymphocyte ratio (NLR) as a predictor of disease severity and mortality in geriatric patients with COVID-19. Materials and Methods: 200 geriatric inpatients infected with COVID-19 were included in the study. Neutrophil lymphocyte ratio (NLR) at admission was recorded. Neutrophil lymphocyte ratio (NLR) cutoff was taken 3.5. Patients were categorized into mild, moderate, severe and critical cases according to criteria given by Maharashtra Task Force. Relationship between Neutrophil lymphocyte ratio (NLR) and disease outcome was assessed. A p value < 0.05 was taken as statistically significant. Results: The mean age of study sample was 69.00 ±7.09 years. A significant association was found between Neutrophil lymphocyte ratio (NLR) and disease severity (p -0.048) as well as mortality (p-0.041).
Files
IJPCR,Vol15,Issue4,Article57.pdf
Files
(490.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ffb2158410c5c738af1fe3f43bb77574
|
490.8 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-03-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue4,Article57.pdf
- Development Status
- Active
References
- 1. https://covid19.who.int/region/searo/cou ntry/in,WHO coronavirus disease (COVID19) Dashboard. 2. Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D'Agnano V, Komici K, Mazzarella G, Parrella R, Bianco A. COVID-19 and the elderly: insights into pathogenesis and clinical decisionmaking. Aging clinical and experimental research. 2020 Aug;32(8):1599-608. 3. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, Peng Z, Pan H. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. Journal of Clinical Virology. 2020 Jun 1; 127: 104364. 4. Regolo M, Vaccaro M, Sorce A, Stancanelli B, Colaci M, Natoli G, Russo M, Alessandria I, Motta M, Santangelo N, Fiorito L. Neutrophil-to-Lymphocyte Ratio (NLR) is a promising predictor of mortality and admission to intensive care unit of COVID-19 patients. Journal of clinical medicine. 2022 Apr 16; 11(8): 2235. 5. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HH, Luo M, Chen L, Zhao Y. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.Journal of infection. 2020 Jul 1;81(1): e6- 12 6. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Tian DS. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical infectious diseases. 2020 Jul 28; 71(15):762-8. 7. Rathod BD, Amle D, Khot RS, Prathipati KK, Joshi PP. Neutrophil-toLymphocyte ratio as a predictor of disease severity and mortality in coronavirus disease 2019: Prospective study From Central India. Cureus. 2022 Mar 31;14(3). 8. Maharashtra COVID-19 Task Force Recommendations for the Management of Hospitalized COVID-19 Patients, 13 August 2020 9. Textbook of Biostatistics and Epidemiology, A primer for Health and Biomedical professionals by Sylvia Wassertheil- Smoller, Third edition. 10. Toori KU, Qureshi MA, Chaudhry A, Safdar MF. Neutrophil to lymphocyte ratio (NLR) in COVID-19: A cheap prognostic marker in a resource constraint setting. Pakistan Journal of medical sciences. 2021 Sep;37(5):1435. 11. Li X, Liu C, Mao Z, Xiao M, Wang L, Qi S, Zhou F. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID19 patients: a systematic review and meta-analysis. Critical Care. 2020 Dec;24(1):1-0. 12. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, dNLR and PLR in COVID-19 patients. International immunopharmacology. 2020 Jul 1; 84:106504. 13. Lian J, Hao S, Zhang X, Yang M, Jin X, Lu Y, Hu J, Zhang S, Zheng L, Jia H, Cai H. High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study. Aging (Albany NY). 2020 Jul 7;12(14):13849. 14. Mo P, Xing Y, Xiao YU, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, Luo M. Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China. Clinical infectious diseases. 2021 Dec 1;73(11): e4208-13.